Since 2014, the global Digital Health ecosystem has been a magnet for venture capital, attracting over $268 billion through more than 20,000 deals worldwide. This surge in funding underscores the sector’s financial value in Digital Health, with investors recognizing the significant potential in digital healthcare solutions. Regions such as North America, Asia-Pacific, and Europe have emerged as key areas of growth, fueled by this increased investment.
A key indicator of the sector’s potential lies in the high returns achieved by exit-stage ventures. In recent years, over 1,480 Digital Health companies have exited, and major M&A deals in 2023–2024 have posted a median return on invested capital (ROIC) of 7.2. This data reflects a strong trend of profitability, validating the sector’s appeal to investors.
Moreover, exit-bound ventures have demonstrated clear operational advantages over their private counterparts, excelling in metrics like team strength, strategic partnerships, and innovation. These qualities highlight the operational excellence that drives successful exits in Digital Health, reaffirming the role of strategic capabilities in advancing healthcare technology.
This report is powered by HealthTech Alpha, a leading provider of comprehensive data and insights in the digital health sector. With a focus on the evolving landscape of healthcare technology, HealthTech Alpha harnesses its extensive database and expertise to analyze trends and innovations that are shaping the future of medtech. By leveraging robust data analytics and market intelligence, HealthTech Alpha enables stakeholders—from investors to medical device manufacturers—to make informed decisions and strategically navigate the complexities of digital transformation in healthcare. Through this collaboration, the report offers valuable perspectives on the intersection of digital health and medtech, equipping readers with the knowledge to understand and engage with this rapidly changing industry.
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com
ABOUT GALEN GROWTH | ||
HEADLINES: 12 pages, 19 charts, 4 tables | ||
ECOSYSTEM INSIGHTS: 8 pages, 9 charts, 5 tables | ||
INVESTMENT INSIGHTS: 4 pages, 6 charts, 2 tables | ||
CLUSTER FOCUS: 4 pages, 6 charts, 1 table | ||
DEEP DIVES: 25 pages, 30 charts, 6 tables | ||
KEY INFORMATION |